Literature DB >> 20689423

Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas.

Margaret Kosek1, Pablo Peñataro Yori, Maribel Paredes Olortegui.   

Abstract

PURPOSE OF REVIEW: Shigella is the principal cause of clinical dysentery and an important cause of morbidity and mortality among children in impoverished regions. The purpose of this review is to present key findings in the areas of epidemiology, disease control, and treatment of shigellosis. RECENT
FINDINGS: Recent research activity has advanced the understanding of the epidemiology and host-pathogen interactions. Increased investment and activity in the area of vaccine development have lead to a diversification of candidates and ongoing technical advances yet continue to yield disappointing results in clinical trials in endemic populations and among the most relevant age groups (children under 2 years of age). The description of the rapid spread of quinolone resistance requires monitoring to ensure appropriate case management, particularly in south-east Asia. The evaluation of adjunctive nutritional therapy in endemic areas has supported the use of green bananas in shortening the duration of Shigella dysentery and persistent diarrhea due to Shigella, as well as improving weight gain in early convalescence.
SUMMARY: Despite a great level of activity in basic sciences, there continues to be a large gap in the ability to translate these findings into disease control measures or therapeutic options for individuals living in areas in which shigellosis is endemic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20689423      PMCID: PMC6892429          DOI: 10.1097/QCO.0b013e32833da204

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  46 in total

Review 1.  Reactive arthritis: clinical aspects and medical management.

Authors:  John D Carter; Alan P Hudson
Journal:  Rheum Dis Clin North Am       Date:  2009-02       Impact factor: 2.670

Review 2.  Shigella infection of intestinal epithelium and circumvention of the host innate defense system.

Authors:  Hiroshi Ashida; Michinaga Ogawa; Hitomi Mimuro; Chihiro Sasakawa
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 3.  Clinical practice. Bacterial diarrhea.

Authors:  Herbert L DuPont
Journal:  N Engl J Med       Date:  2009-10-15       Impact factor: 91.245

Review 4.  Epidemiologic aspects of shigellosis and other causes of dysentery in Thailand.

Authors:  D N Taylor; L Bodhidatta; P Echeverria
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

5.  Characteristics of children with Shigella encephalopathy: experience from a large urban diarrhea treatment center in Bangladesh.

Authors:  Mohammod Jobayer Chisti; Abu Syed Golam Faruque; Wasif Ali Khan; Sumon Kumar Das; Mir Borhan Zabed; Mohammed Abdus Salam
Journal:  Pediatr Infect Dis J       Date:  2010-05       Impact factor: 2.129

6.  Emergence of resistance to third-generation cephalosporin in Shigella--a case report.

Authors:  Jharna Mandal; Nivedita Mondal; S Mahadevan; Subhash Chandra Parija
Journal:  J Trop Pediatr       Date:  2009-12-02       Impact factor: 1.165

7.  Characterisation of early mucosal and neuronal lesions following Shigella flexneri infection in human colon.

Authors:  Emmanuel Coron; Mathurin Flamant; Philippe Aubert; Thilo Wedel; Thierry Pedron; Eric Letessier; Jean P Galmiche; Philippe J Sansonetti; Michel Neunlist
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

Review 8.  Antibiotics for the treatment of dysentery in children.

Authors:  Beatrix S Traa; Christa L Fischer Walker; Melinda Munos; Robert E Black
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

9.  A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.

Authors:  Armelle Phalipon; Myriam Tanguy; Cyrille Grandjean; Catherine Guerreiro; Frédéric Bélot; Dani Cohen; Philippe J Sansonetti; Laurence A Mulard
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

10.  Magnitude of drug resistant Shigellosis: a report from Bangalore.

Authors:  H Srinivasa; M Baijayanti; Y Raksha
Journal:  Indian J Med Microbiol       Date:  2009 Oct-Dec       Impact factor: 0.985

View more
  17 in total

Review 1.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Tyrosine kinases, drugs, and Shigella flexneri dissemination.

Authors:  Ana-Maria Dragoi; Hervé Agaisse
Journal:  Gut Microbes       Date:  2013-09-19

3.  Human Intestinal Enteroids as a Model System of Shigella Pathogenesis.

Authors:  Benjamin J Koestler; Cara M Ward; C R Fisher; Anubama Rajan; Anthony W Maresso; Shelley M Payne
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

4.  Establishment of a Shigella sonnei human challenge model in Thailand.

Authors:  Ladaporn Bodhidatta; Punnee Pitisuttithum; Supat Chamnanchanant; Karen T Chang; Dilara Islam; Valai Bussaratid; Malabi M Venkatesan; Thomas L Hale; Carl J Mason
Journal:  Vaccine       Date:  2012-10-12       Impact factor: 3.641

Review 5.  PulseNet China, a model for future laboratory-based bacterial infectious disease surveillance in China.

Authors:  Wei Li; Shan Lu; Zhigang Cui; Jinghua Cui; Haijian Zhou; Yiqing Wang; Zhujun Shao; Changyun Ye; Biao Kan; Jianguo Xu
Journal:  Front Med       Date:  2012-11-03       Impact factor: 4.592

Review 6.  [Drug therapy of infectious diarrhea: part 1: acute diarrhea].

Authors:  C Lübbert; S Weis
Journal:  Internist (Berl)       Date:  2013-11       Impact factor: 0.743

7.  Broadly protective Shigella vaccine based on type III secretion apparatus proteins.

Authors:  Francisco J Martinez-Becerra; Julian M Kissmann; Jovita Diaz-McNair; Shyamal P Choudhari; Amy M Quick; Gabriela Mellado-Sanchez; John D Clements; Marcela F Pasetti; Wendy L Picking
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

8.  Convergent synthesis of the tetrasaccharide repeating unit of the O-antigen of Shigella boydii type 9.

Authors:  Abhishek Santra; Anup Kumar Misra
Journal:  Beilstein J Org Chem       Date:  2011-08-29       Impact factor: 2.883

9.  Molecular diagnosis of diarrhea: current status and future potential.

Authors:  James A Platts-Mills; Darwin J Operario; Eric R Houpt
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

10.  Genetic characterization of antimicrobial resistance of Shigella flexneri 1c isolates from patients in Egypt and Pakistan.

Authors:  Salwa F Ahmed; John Klena; Tupur Husain; Jesse Monestersky; Amel Naguib; Momtaz O Wasfy
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-05-02       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.